Upload Avatar (500 x 500)
谢娜
xnshina@126.com
中文, 英文
四川
四川大学
West China Institute of Basic Medicine and Forensic Medicine
  • 2014年 - 博士学位: 四川大学生物治疗国家重点实验室
  • 成就: 以第一作者或通讯作者发表20余篇学术论文,其中4篇入选ESI高被引论文
  • 2015-2019年 - 南加州大学 - 访问学者
  • 博士后研究 - 四川大学华西医院
  • 教育部自然科学奖一等奖: 第九完成人
  • 入选第十四批四川省学术和技术带头人后备人选
病毒诱导肿瘤发生发展过程中的相互作用网络
氧化应激
代谢调控
细胞自噬机制及干预策略
  • Neoantigens: promising targets for cancer therapy, Xie N*, Shen G*, Gao W, Huang Z, Huang C#, Fu L#, 2023
  • Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer, Li L, Tian H, Zhang Z, Ding N, He K, Lu S, Liu R, Wu P, Wang Y, He B, Luo M, Peng P, Yang M, Nice EC, Huang C, Xie N#, Wang D#, Gao W#, 2023
  • Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer, Chen X, Feng L, Huang Y, Wu Y, Xie N#, 2023
  • Nanoengineering a Zeolitic Imidazolate Framework-8 Capable of Manipulating Energy Metabolism against Cancer Chemo-Phototherapy Resistance, Lu S, Tian H, Li L, Li B, Yang M, Zhou L, Jiang H, Li Q, Wang W, Nice EC, Xie N#, Huang C#, Liu L#, 2022
  • Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling, Duan J, Huang Z, Nice EC, Xie N#, Chen M#, Huang C#, 2022
  • Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies, Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N#, Huang C#, Shen Z#, 2022
  • Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges, Zhang Y, Li J, Gao W#, Xie N#, 2022
  • Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications, Wu P, Han J, Gong Y, Liu C, Yu H#, Xie N#, 2022
  • Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma, An Y, Jiang J, Zhou L, Shi J, Jin P, Li L, Peng L, He S, Zhang W, Huang C, Zou B#, Xie N#, 2021
  • From purines to purinergic signalling: molecular functions and human diseases, Huang Z*, Xie N*, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y, 2021
  • Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment, Wu P*, Gao W*, Su M, Nice EC, Zhang W, Lin J#, Xie N#, 2021
  • NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Xie N*, Zhang L*, Gao W*, Huang C, Huber PE, Zhou X, Li C#, Shen G#, Zou B#, 2020
  • Managing therapeutic resistance in breast cancer: from the lncRNAs perspective, Peng L, Jiang J, Tang B, Nice EC, Zhang YY#, Xie N#, 2020
  • Overcoming cancer therapeutic bottleneck by drug repurposing, Zhang Z*, Zhou L*, Xie N*, Nice EC, Zhang T, Cui Y, Huang C, 2020
  • PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation, Xie N*, Yuan K*, Zhou L, Wang K, Chen HN, Lei Y, Lan J, Pu Q, Gao W, Zhang L, Shen G, Li Q, Xiao H, Tang H, Xiang R, He M, Feng P, Nice EC, Wei Y, Zhang H, Yang J, Huang C, 2016
病毒诱导肿瘤 相互作用网络 氧化应激 代谢调控 细胞自噬 干预策略 癌症治疗 免疫反应 纳米颗粒 药物递送

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。